NASDAQ:BIOX • KYG1117K1141
Past quarterly earnings results for BIOCERES CROP SOLUTIONS CORP (BIOX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | -0.12 | -0.07 | -62.27% | -33.33% | 77.3M | 92.03M | -16.01% | -16.52% |
| Q4 2025 | -0.70 | 0.08 | -1,015.03% | -2,233.33% | 74.7M | 113.91M | -34.42% | -39.76% |
| Q3 2025 | -0.02 | -0.15 | 86.93% | -114.29% | 60.6M | 65.212M | -7.07% | -27.86% |
| Q2 2025 | 0.01 | 0.09 | -89.82% | -52.63% | 106.8M | 132.09M | -19.15% | -23.82% |
| Q1 2025 | -0.09 | -0.01 | -1,076.47% | -28.57% | 92.6M | 111.44M | -16.91% | -20.58% |
| Q4 2024 | -0.03 | 0.25 | -112.05% | 50.00% | 124M | 138.07M | -10.19% | 18.43% |
| Q3 2024 | 0.14 | 0.17 | -19.26% | -68.18% | 84M | 100.47M | -16.39% | -10.26% |
| Q2 2024 | 0.02 | 0.09 | -79.75% | 113.57% | 140.2M | 119.33M | 17.49% | 50.75% |
| Q1 2024 | -0.07 | 0.06 | -219.35% | -975.00% | 116.6M | 126.29M | -7.67% | -7.90% |
| Q4 2023 | -0.06 | 0.05 | -227.88% | 27.71% | 104.7M | 109.81M | -4.65% | 1.16% |
| Q3 2023 | 0.44 | -0.03 | 1,759.13% | 378.48% | 93.605M | 90.181M | 3.80% | 38.88% |
| Q2 2023 | -0.14 | 0.07 | -303.34% | -275.00% | 93M | 93.824M | -0.88% | 2.09% |
| Q1 2023 | 0.01 | 0.05 | -83.66% | -60.00% | 126.6M | 83.63M | 51.38% | 90.66% |
| Q4 2022 | -0.08 | 0.16 | -150.86% | -515.00% | 103.5M | 96.792M | 6.93% | 27.62% |
| Q3 2022 | -0.16 | -0.08 | -99.87% | -409.68% | 67.4M | 45.631M | 47.71% | 89.86% |
| Q2 2022 | 0.08 | 0.05 | 49.39% | 370.59% | 91.1M | 71.384M | 27.62% | 89.79% |
| Q1 2022 | 0.02 | 0.09 | -78.80% | 110.53% | 66.4M | 51.214M | 29.65% | 57.72% |
| Q4 2021 | 0.02 | 0.27 | -92.60% | -66.67% | 81.1M | 55.007M | 47.44% | 68.61% |
| Q3 2021 | -0.03 | -0.05 | 39.22% | 65.56% | 35.5M | 27.967M | 26.94% | 38.13% |
| Q2 2021 | 0.02 | 0.37 | -95.37% | -94.52% | 48M | 68.952M | -30.39% | -22.95% |
| Q1 2021 | -0.19 | 0.08 | -332.84% | -111.11% | 42.1M | 40.8M | 3.19% | 15.98% |
| Q4 2020 | 0.06 | 0.22 | -72.64% | - | 48.1M | 50.813M | -5.34% | - |
| Q3 2020 | -0.09 | -0.12 | 23.27% | - | 25.7M | 20.4M | 25.98% | - |
| Q2 2020 | 0.31 | 0.34 | -7.90% | - | 62.3M | 71.4M | -12.75% | - |
| Q1 2020 | -0.09 | - | - | 36.3M | - | - |
Notes
BIOCERES CROP SOLUTIONS CORP (BIOX) last reported earnings on 2/5/2026.
BIOCERES CROP SOLUTIONS CORP (BIOX) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, BIOCERES CROP SOLUTIONS CORP (BIOX) has beaten EPS estimates in 1 out of 4 releases.